B-46178093 - ¿EXISTE EVIDENCIA SUFICIENTE PARA JUSTIFICAR EL IMPLANTE DE TAVI EN EDADES MENOR QUE 70 AÑOS RECOMENDADO EN LAS GUÍAS DE PRÁCTICA CLÍNICA ESC-EACTS DE 2025?
Elio Martín Gutiérrez, Sergio Juan Cánovas López, Maydelin Lorenzo Diaz, Francisco Gutiérrez García, Juan M. Jiménez(University of Pennsylvania), Rosario Albarracín García, R S José Castañeda, C Bonet, Julio García-Puente del Corral, Joaquín Pérez Andreu, Jose María Arribas Leal, Manuel Fernández Molina(Universidad de Murcia), Ramon Aranda Domene, Laura Alfonso Colomer, María José Alcaraz García(Jewish General Hospital)
Cited by 0
Related Papers
Seminal plasma antioxidants are directly involved in boar sperm cryotolerance
|Theriogenology|2017|76
Macro- and microscale variables regulate stent haemodynamics, fibrin deposition and thrombomodulin expression
|Journal of The Royal Society Interface|2014|57
IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia
|PLoS ONE|2015|49
Dock10, a novel CZH protein selectively induced by interleukin-4 in human B lymphocytes
|Molecular Immunology|2008|46
Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
|International Journal of Infectious Diseases|2021|42